Document is current

Any future updates will be listed below

The sGC-stimulator Riociguat for the treatment of Raynaud's phenomenon: A single-dose, double-blind, randomized, placebo-controlled cross-over study (DIGIT)

Crossref DOI link: https://doi.org/10.1186/2050-6511-16-S1-A58

Published Online: 2015-09-02

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark